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Neurally adjusted ventilatory assist (NAVA) is a mode of ventilation wherein the delivered
assistance is proportional to diaphragm electrical activity (EAdi) throughout inspiration. We as-
sessed the physiologic response to varying levels of NAVA and pressure support ventilation
(PSV) in 13 tracheostomised patients with prolonged weaning.
Each patient randomly underwent 8 trials, at four levels of assistance either in PSV and
NAVA. i e high (no dyspnoea and/or distress); iv e low (associated with dyspnoea and/or
distress; ii and iii e atw75% andw25% of the difference between high and low support respec-
tively. We measured tidal volume (VT), peak EAdi, (EAdipeak) and airway pressure, ineffective
efforts and breathing pattern variability.
With both NAVA and PSV, decreasing assistance resulted in parallel significant increase in EA-
dipeak associated with a concomitant reduction in VT and minute ventilation in PSV, but not in
NAVA. VT variability significantly increased when reducing ventilatory assistance in PSV only,
while remained unchanged varying the NAVA level. The ineffective triggering index was not
significantly different between the two modes.Rehabilitation Unit, Auxilium Vitae Rehabilitation Centre, Borgo S. Lazzaro, Volterra, Italy. Tel.: þ39
gmail.com, n.ambrosino@ao-pisa.toscana.it (N. Ambrosino).
3 Elsevier Ltd. All rights reserved.
13.08.013
Physiologic response in prolonged weaning 1749In patients with prolonged weaning, with the specific settings adopted, compared to PSV,
NAVA reduced the risk of over-assistance and overall improved patienteventilator interaction,
while not significantly affecting patienteventilator synchrony.
ª 2013 Elsevier Ltd. All rights reserved.Introduction
According to a recent Task Force, patients with “pro-
longed weaning” are those failing at least 3 attempts or
requiring more than 7 days of weaning from mechanical
ventilation (MV) after the first spontaneous breathing trial
[1]. These patients, represent up to 14% of patients
admitted to intensive care unit (ICU) for invasive MV, and
spend a great amount of resources with relatively poor
outcomes [2], with an in-hospital mortality as high as 32%
[3].
Pressure support ventilation (PSV) is a widely used
mode of partial ventilatory assistance. Although with this
mode, ventilator cycling is ideally under control of the
patient’s own respiratory drive and rhythm [4], a poor
interaction between patient and machine may occur
[5e7].
Neurally adjusted ventilatory assist (NAVA) is a mode
recently introduced in the clinical use in which the machine
applies positive pressure throughout inspiration in propor-
tion to the electrical activity of the diaphragm (EAdi),
which is the closest available signal to the neural output of
the respiratory centres and thus the best indicator of the
neural drive to breathe [8]. In NAVA, the ventilator is
triggered and cycled off by the EAdi signal [8,9], and the
support delivered by the ventilator is instantaneously pro-
portional to EAdi. The level of assistance for a given EAdi is
regulated by a gain factor (NAVA level) set on the ventilator
[10,11].
Physiologic comparisons between PSV and NAVA have
been performed in ICU patients with acute respiratory
failure [9e11], in postoperative patients [12], in patients
recovering from acute respiratory distress syndrome [13],
and during non-invasive ventilation [14]. So far, however,
no study has compared PSV and NAVA in patients with
prolonged weaning [15]. As patients with prolonged MV
have improved mechanics but weak respiratory muscles,
we wonder whether they respond differently to NAVA
compared with patients in acute respiratory failure. Aim
of the present study is, therefore, assessing and
comparing in patients with prolonged weaning the physi-
ologic effects of varying levels of ventilator assistance in
PSV and NAVA.
Materials and methods
The integrated 8-bed WU is located inside a 20 bed pul-
monary rehabilitation unit of a Rehabilitation Hospital
(Auxilium Vitae), in Volterra, which is a referral rehabil-
itation and chronic care centre for a large geographic
area in central Italy (Tuscany). It is staffed with a 1:6
nurse to patient ratio, a 24-h on duty doctor shared with
the pulmonary rehabilitation unit, a 1:6 respiratorytherapist to patient ratio. Psychological, speech, nutri-
tion and swallowing services are also available. Difficult-
to wean tracheostomised patients are admitted to the
WU, transferred from ICUs of Tuscany Hospitals to un-
dergo either a program of progressive discontinuation
from MV or to be discharged to a home program of long-
term ventilatory assistance, if weaning from the venti-
lator fails [7,16].
Patients
From December 2010 to June 2011, all tracheostomised
conscious patients with prolonged weaning were consid-
ered eligible. Exclusion criteria were: 1) age <18 years; 2)
history of oesophageal varices; 3) gastro-oesophageal
bleeding in the previous 30 days; 4) gastro-oesophageal
surgery in the previous 6 months; 5) haemodynamic insta-
bility as defined by need of infusion of vasopressors, despite
adequate fluid filling to maintain systolic blood pressure
>90 mmHg; 7) coagulation disorders (INR ratio >1.5 or aPTT
>4400 or blood platelet count <70.000/fl); 8) core temper-
ature >38 C; 9) stroke in the previous 30 days; 10) un-
controlled arrhythmias causing symptoms or haemodynamic
compromise; 11) acute pulmonary embolism or pulmonary
infarction in the previous 60 days; 12) severe untreated
arterial hypertension at rest (>200 mmHg systolic,
>120 mmHg diastolic); 13) mental impairment leading to
inability to cooperate; 14) refusal to participate to the
study, and 15) inclusion in other research protocols.
Measurements and data analysis
Patients were ventilated using a Servo-I ventilator
(Maquet Critical Care, Solna, Sweden), equipped with
NAVA module and software. Airway pressure (Paw),
airflow and EAdi signals were acquired at 100 Hz from the
ventilator via a RS232 interface connected to a computer
using commercially available software (Servo-tracker
v4.0, Maquet Critical Care) during the last 3 min of
recording of 5 min application of each level of assistance.
Data were stored in a personal computer for off-line anal-
ysis, performed by means of custom software routines
developed under Matlab environment (Mathworks, Inc.,
Natick, MA, USA). Airway pressure, airflow, tidal volume
(VT) and minute ventilation (VE), peak Paw (Pawpeak), were
extracted from the ventilator data output. Peak EAdi
(EAdipeak), neural respiratory rate (RRneur) and inspiratory
duty cycle (TI/TTOT-neur) were obtained from the EAdi
signal.
Ineffective triggering, as defined by the lack of corre-
spondence between an EAdi signal level of at least equal
amplitude as that of NAVA triggering and pressure and
airflow signals (Fig. 1), were evaluated at the highest level
Figure 1 Example of tracing from one representative patient breathing with PSV, showing an ineffective effort (Star).
1750 G. Vagheggini et al.of assistance during the last 3 min of recording. We calcu-
lated the ineffective triggering index (ITI) as the number of
ineffective efforts divided by the total respiratory rate (i.e.
the sum of ventilator cycles plus ineffective efforts)
[17,18].
Dyspnoea was assessed by means of a modified Borg
Scale [19]. Pulsoxymetry (SpO2) and heart rate were
monitored throughout the whole study during all trials.
Study protocol
The whole protocol was performed in the same day. Each
patient randomly underwent 8 trials, at four levels of
assistance either in PSV and NAVA. Level 1 (high assistance)
was first determined for PSV as the lowest inspiratory
support capable to achieve a value 2 on the modified Borg
Scale without any sign of respiratory distress such as
tachypnoea, accessory muscles recruitment, tachycardia
and/or hypertension, worsening of SpO2. The corresponding
Level 1 in NAVA was then determined using a dedicated
function of the ventilator (“NAVA preview”), which pro-
vides during PSV an estimate of the NAVA level achieving an
equivalent Pawpeak. The inspiratory assistance was then
progressively reduced with both modes to a level of assis-
tance associated with dyspnoea 6 on the Borg scale and/
or at least one of the aforementioned signs of respiratory
distress (Level 4: low assistance). With both modes Levels 2
(moderate high assistance) and 3 (moderate low assistance)
were defined as intermediate levels of ventilatory support
at w75% and w25% of the support difference between
Level 1 and Level 4. Each level of assistance lasted 5 min. A
20 min wash out period was allowed between each trial
during which patients underwent their individual baseline
MV setting.
The manufacturer ventilator default settings were used
for all patients. Onset and end of inspiration were triggeredby flow and EAdi signals, in PSV and NAVA, respectively [8].
Positive end expiratory pressure (PEEP: 6.6  1.2 cm H2O)
and inspired oxygen fraction (FiO2: 0.30  0.07) were those
in use prior to the study and were maintained constant
throughout the whole study period.
Statistical analysis
Different levels within the same ventilator modality were
compared using one way repeated measures analysis of
variance (ANOVA), and Friedman repeated measures ANOVA
on Ranks test in case of failure of normality test. One-way
ANOVA, and KruskaleWallis One-way ANOVA in case of
failure of normality test were used to compare the same
level in NAVA vs PSV. The post-hoc pairwise multiple com-
parison procedure was performed using Holm-Sidak
method, and Tukey Test in case of failure of normality
test. The coefficient of variation (CV) was also calculated
as standard deviation to mean ratio multiplied by 100. ITI
was compared between the two modes using Fisher’s exact
test.
Results
We enrolled 13 consecutive patients. Patients’ individual
demographic, physiological and clinical characteristics on
study entry are shown in Table 1.
PEEP and FiO2 were 6.6  1.2 cm H2O and 0.30  0.07,
respectively. SpO2 did not remarkably vary throughout all
trials in all patients, ranging from 92 to 94%. Heart rate did
not change along the study in any patient.
Fig. 2 shows the relationship between VT and diaphrag-
matic activity as assessed by EAdipeak, at each level of
assistance. With both NAVA and PSV, reducing the level of
assistance (described by the number inside the symbol)
Table 1 Individual demographic, physiological and clinical characteristics of patients at study time.
ID Sex Age Days
of MV




1 F 82 19 Septic shock, bowel obstruction 7.44 297.6 38.9 6
2 F 76 117 Coronary artery bypass graft surgery 7.39 212.3 45.9 6
3 F 81 13 GuillaineBarre´ syndrome 7.45 328.0 34.4 6
4 M 76 84 AECOPD, cor pulmonale 7.36 223.3 58.3 8
5 F 71 60 Community acquired pneumonia, AECOPD 7.39 190.0 47.4 6
6 M 27 87 Polytrauma 7.43 246.0 45.8 8
7 M 47 10 Severe Influenza H1N1 related Pneumonia 7.47 211.7 38.0 6
8 M 73 11 Severe community acquired multifocal pneumonia 7.44 150.5 50.8 6
9 M 61 32 Community acquired pneumonia, AECOPD 7.39 288.7 46.8 6
10 F 54 33 Kyphoscoliosis, community acquired pneumonia 7.42 336.7 43.9 8
11 F 78 32 Acute myocardial infarction, heart failure 7.38 263.0 34.2 6
12 M 68 58 Community acquired pneumonia, AECOPD 7.40 257.0 47.0 6
13 F 67 32 Interstitial pneumonia in refractory anaemia
with excess blasts in transformation
7.48 253.0 33.4 6
Abbreviations. MV: mechanical ventilation; AECOPD: acute exacerbation of chronic obstructive pulmonary disease. TX I.D. Tracheos-
tomy cannula inner diameter.
Arterial blood gases were assessed under MV.
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(p Z 0.003 and 0.001 for NAVA and PSV, respectively),
whereas a concomitant reduction in VT (p Z 0.001) and VE
(p Z 0.015) was observed in PSV, while not in NAVA (Table
2). The same Fig. 2 shows that as expected and as also
shown in Table 2, Pawpeak decreased (p Z 0.001) with
reduction in level of assistance with both modalities,
without any significant difference between modalities at
any level of assistance. As also shown in Table 2, neural
respiratory rate (RRneur) did not change with different
levels of NAVA assistance, whereas it significantly increased
with decreasing levels of PSV assistance. Inspiratory dutyFigure 2 Relationship between VT and EAdi peak (mean
values) at different levels of assistance in NAVA and PSV. Ori-
zontal and vertical bars represent SD of EAdi peak and VT
respectively. Each level of assistance is described by the
number inside the symbol. 1. High assistance; 2. Moderate high
assistance; 3. Moderate low assistance; 4. Low assistance.
Numbers represent Pawpeak at each level of assistance.cycle (TI/TTOT-neur) did not change with any level of assis-
tance with any modality. Table 2 shows also that VT vari-
ability, as assessed by CV significantly increased by
reducing the inspiratory assistance in PSV only, and at each
level resulted higher in NAVA than in PSV.
ITI exceeded 10% in only one patient in PSV and was
therefore not significantly different between the 2 modes.
Borg score reported by the patients at the lowest level of
assistance did not differ between NAVA and PSV
(4.86  2.53 vs 5.00  2.5; p Z 0.56).Discussion
We studied the breathing pattern in NAVA and pressure PSV
of tracheostomized patients with prolonged weaning. Four
different levels of assistance are applied in NAVA and in
PSV. The main results were: 1) increasing the level of
assistance resulted in VT in PSV but not in NAVA, suggesting
that NAVA reduces the risk of overdistention, 2) VT vari-
ability was higher in NAVA than in PSV and increased when
the PSV level decreased while did not change according to
the level of assistance in NAVA, 3) ineffective triggering was
similar in the two groups.
This is the first work to titrate NAVA according to two
major respiratory signs: dyspnoea and respiratory distress,
whereas previous studies have proposed to titrate the NAVA
level according to various physiological signs such as tidal
volume or respiratory rate [20]. Furthermore while several
previous studies have compared PSV and NAVA in ICU pa-
tients receiving invasive [9e13,21] and non-invasive venti-
lation [14,19,21e23], this is, to our knowledge, the first
investigation performed in patients with prolonged weaning.
Indeed, this patient population is continuously increasing
and recent estimates indicate the existence of more than
100,000 of these patients in the United States [24].
Although PSV has been proven to be valuable in several
clinical conditions, dyssynchronies and in particular



























13.1  4.0 9.2  2.8 5.9  2.5 2.4  2.6
NAVA gain
[cmH2O/mV]
1.8  0.5 1.3  0.4 0.8  0.3 0.4  0.3
VT [ml/kg] 4.96  2.09 5.09  2.36 4.66  1.89 4.29  1.63 6.27  1.63 5.33  1.66** 4.70  1.36**,## 4.37  1.43##
VE [l/kg min] 0.12  0.05 0.12  0.06 0.12  0.05 0.11  0.04 0.14  0.04 0.13  0.05 0.13  0.04 0.12  0.04#
RRneur [breath/min] 28.48  8.14 28.19  7.85 28.45  7.60 29.02  7.90 24.19  6.28 28.56  9.75 28.72  7.77*,# 30.15  7.73##
TI/TTOT-neur 45.10  4.23 46.05  5.09 46.03  4.97 45.43  4.48 46.37  4.89 45.84  4.73 44.82  4.04 44.86  3.29
Pawpeak [cmH2O] 19.62  6.23 18.41  6.56 16.68  6.17## 13.64  5.38## 20.55  4.48 16.80  3.75** 13.69  3.52## 11.10  2.67##
EAdipeak [mV] 8.57  5.54 9.74  6.60 12.28  9.66## 15.59  13.25## 9.98  7.65 13.24  12.45 17.23  15.28**,## 19.99  19.49##
CV-VT 0.34  0.10xx 0.30  0.09xx 0.30  0.13xx 0.30  0.18x 0.07  0.04 0.10  0.04 0.13  0.08# 0.17  0.13##
Data are expressed as mean  SD.
VT, tidal volume; VE, minute ventilation; RRneur, Neural respiratory rate; TI/TTOT-neur: Neural duty cycle; Paw, airway pressure; EAdi, electrical activity of the diaphragm; CV, coefficient of
variation.
*P < 0.05 between consecutive levels.
**P < 0.001 between consecutive levels.
#P < 0.05 with level 1.
##P < 0.001 with level 1.
xP < 0.05 NAVA vs PSV at equivalent level of assistance.














Physiologic response in prolonged weaning 1753ineffective triggerings, have been frequently reported with
this mode [6,18]. Ineffective triggering may be secondary
to multiple factors, including machine characteristics and
performance, patient’s breathing pattern, inspiratory
muscle strength, mechanical properties of the respiratory
system, and factors affecting neural respiratory drive, such
as deep sedation [17] and over-assistance [7,9]. In keeping
with previous studies evaluating other patient populations
[9,10,12,13,22,25e27], we found that NAVA reduces the
risk of overassistance. In fact, VT was significantly higher at
Level 1, i.e., the highest assistance, as opposed to the
other three levels, in PSV, while there was no difference
among trials in NAVA. However, because of the criteria used
to set the highest assistance in PSV, the average VT at Level
1, though significantly higher, was only slightly exceeding
6 ml/kg. This explains the low rate of ineffective triggerings
observed in the present study, as opposed to previous
investigation in which high levels of PSV determined much
higher tidal volumes and significant increases in the
occurrence of asynchronies [9,27]. In fact, these data
confirm the results of Thille et al. [28] who showed that
reducing VT by decreasing the amount of inspiratory assis-
tance in PSV produces a significant fall in asynchronies
between patient effort and ventilator assistance.
As already reported by several previous studies, we
confirm also in patients with prolonged weaning that,
compared to PSV, NAVA increases VT variability. The high VT
variability with NAVA was at a comparable level of support
when compared with PSV rather than with the reduction of
ventilatory support. Schmidt et al. [29] applied NAVA during
weaning from MV in ICU patients and found, compared to
PSV, a higher complexity of the breathing pattern more
closely mimicking natural ventilation, NAVA might result in
improved interaction between patient’s demand and
ventilatory support.
Though we confirm in patients with prolonged weaning
these previous findings, because of the nature of the pre-
sent article, i.e., a short term physiologic study, we do not
know whether the improved breath-by-breath interaction
between patient’s demand and ventilatory support may
positively affect the outcome of the weaning process.
Our study has limitations that deserve discussion. First,
we did not measure arterial blood gases. While in the acute
patient in ICU arterial blood is commonly drawn from an
arterial line utilised for continuous arterial pressure moni-
toring, obtaining arterial blood gases in our patients would
have meant to puncture 8 times each of them, which could
have led to a high rate of refusals to participate in the study
by the patients. On one side, as SpO2 did not change in any
patient throughout the study period, however, we may argue
that, as shown in previous studies [9], arterial blood gases
were not different between the 2 modes. In fact, Colombo
et al. [9] who first showed that the physiologic response to
changes in the amount of the ventilator assistance was
different between PSV and NAVA, did not find any significant
difference in arterial blood gases between the 2 modes.
These findings were subsequently confirmed by several other
studies [22,29,30]. Nevertheless, VE did not change with
NAVA settings whereas it did with PSV settings. Because the
decrease in PSV level was associated with a lesser decrease
in VE than in VT, we could hypothesise that alveolar venti-
lation decreased more than VE. Despite a transcutaneousPCO2 monitoring was unavailable the analysis of breathing
pattern therefore might have supported the hypothesis that
PaCO2 did not change between the different NAVA settings,
but increased when the PSV level decreased.
Second, measurements were performed after only
5 min for each mode and level of assist. This time span may
be criticised as not enough to see the different response.
This methodological limit might be even more relevant to
assess the risk of over assistance, asynchrony, fatigability or
distress and might explain the low rate of ineffective trig-
gering observed in the present study.
Third, prolonged weaning may depend on different
causes, which can be grossly related to increased respira-
tory load or reduced muscle force. Because patients with
increased load are characterised by a high drive, diaphragm
activation can be easily detected by the EAdi catheter and
manipulated by varying the NAVA level. On the contrary,
obtaining Eadi in patients with low muscle force may be
problematic. Recent work, however, showed that in most of
the patients with critical illness-associated poly-
neuromyopathy, EAdi and its feedback control were suffi-
ciently preserved to titrate and implement NAVA for up to
three days [31]. Regardless of the underlying disorder, we
were able to obtain a proper EAdi signal and to apply
varying amounts of NAVA level in all the patients included in
our investigation. It is worth remarking, however, that in
specific categories of patients with prolonged weaning,
such as those with postoperative diaphragmatic paralysis, it
would be impossible to detect EAdi and apply NAVA.
In conclusion
With the limitations of small sample size and short time of
measurements, this study confirms in patients with pro-
longed weaning, that NAVA eliminates the risk of over-
assistance. However, it also indicate that the advantages of
NAVA vs PSV are definitely smaller when this latter mode is
carefully set avoiding excessive support causing excessive
Tidal Volumes. Assessing whether NAVA and/or EAdi moni-
toring may help to expedite the weaning process is beyond
the aims of our investigation and warrants further evalua-
tion [32].
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